Are nuclear factors the ultimate targets of drugs affecting lipid metabolism? Jean-Charles Fruchart Invited Commentary Pages: 353 - 354
High-density lipoprotein metabolism: Molecular targets for new therapies for atherosclerosis Masa-aki KawashiriCyrille MaugeaisDaniel J. Rader OriginalPaper Pages: 363 - 372
Gene therapy for myocardial angiogenesis: Has it come of age? Birgit KantorJohn AltmanRobert S. Schwartz OriginalPaper Pages: 373 - 379
Genetics of atherosclerosis: The search for genes acting at the level of the vessel wall Veronica Villa-ColinayoWeibin ShiAldons J. Lusis OriginalPaper Pages: 380 - 389
The role of proteinases in angiogenesis, heart development, restenosis, atherosclerosis, myocardial ischemia, and stroke: Insights from genetic studies Aernout LuttunMieke DewerchinPeter Carmeliet OriginalPaper Pages: 407 - 416
New concepts in fibrinolysis and angiogenesis Katherine A. HajjarArunkumar Deora OriginalPaper Pages: 417 - 421
The good smooth muscle cells in atherosclerosis Stephen M. SchwartzRenu VirmaniMichael E. Rosenfeld OriginalPaper Pages: 422 - 429
Atherosclerosis and diabetes: The rage connection Ann Marie SchmidtDavid Stern OriginalPaper Pages: 430 - 436
New concepts in vascular nitric oxide signaling Richard A. OecklerMichael S. Wolin OriginalPaper Pages: 437 - 444